| PERIOD ENDING | 30-Jun-09 | 30-Jun-08 | 30-Jun-07 | | Total Revenue | 15,381,772 | 16,142,786 | 15,760,674 | | Cost of Revenue | 6,414,716 | 6,475,073 | 6,640,925 | | | Gross Profit | 8,967,056 | 9,667,713 | 9,119,749 | | | Operating Expenses | | Research Development |
-
|
-
|
-
| | Selling General and Administrative | 4,931,220 | 5,225,953 | 5,101,929 | | Non Recurring |
-
|
-
| (118,230) | | Others |
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
| | | | Operating Income or Loss | 4,035,836 | 4,441,760 | 4,136,050 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 290,752 | 367,154 | 422,823 | | Earnings Before Interest And Taxes | 4,597,516 | 5,162,100 | 4,961,656 | | Interest Expense | 1,268,736 | 985,728 | 703,369 | | Income Before Tax | 3,328,780 | 4,176,372 | 4,258,288 | | Income Tax Expense | 482,384 | 1,041,599 | 869,693 | | Minority Interest |
-
|
-
| (198,386) | | | | Net Income From Continuing Ops | 2,846,396 | 3,134,773 | 3,190,209 | | | Non-recurring Events | | Discontinued Operations | 3,304 | 51,880 |
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | 2,849,700 | 3,186,654 | 3,190,209 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,849,700 | $3,186,654 | $3,190,209 |
|
0.34% Nasdaq 0.00%
Income Statement
